7Baggers
Quarterly
Annual
    Unit: USD2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 
      
    		                        
      operating activities
    		                        
      net income
    		13,864,000 17,112,000 15,059,000 10,532,000 10,421,000 16,485,000 16,898,000 13,470,000 15,898,000 14,991,000 17,678,000 3,408,000 13,211,000 8,768,000 4,971,000 15,080,000 16,796,000 18,727,000 15,166,000 38,859,000 5,355,000 -1,812,000 4,057,000 -4,400,000 
      adjustments to reconcile net income to net cash from operating activities:
    		                        
      deferred tax expense
    		8,000 12,000 11,000  4,829,000 2,645,000 2,877,000 -2,117,000 5,038,000          -3,370,000 -38,087,000 0 0 116,000 -77,000 
      non-cash interest expense
    		               0 0 19,000 19,000 19,000 19,000 18,000 19,000  
      depreciation and amortization
    		1,268,000 1,205,000 1,108,000 868,000 837,000 754,000 716,000 634,000 579,000 527,000 541,000 446,000 405,000 386,000 364,000 316,000 267,000 296,000 422,000 464,000 462,000 460,000 520,000 539,000 
      loss on disposal of property and equipment
    		0 0 79,000                     0 
      stock-based compensation expense
    		32,173,000 32,383,000 32,512,000 30,859,000 33,183,000 33,036,000 31,052,000 28,799,000 31,251,000 31,753,000 30,808,000 29,297,000 23,297,000 23,654,000 24,500,000 15,008,000 7,147,000 6,517,000 5,034,000 4,160,000 3,071,000 3,541,000 2,049,000 1,852,000 
      bad debt expense
    		4,328,000 5,358,000 5,659,000 3,662,000 3,162,000 4,800,000 4,772,000 4,872,000 5,268,000 4,550,000 5,244,000 4,109,000 3,588,000 3,816,000 2,281,000 2,562,000 2,416,000 2,287,000 2,518,000 1,853,000 1,240,000 1,212,000 1,257,000 274,000 
      net accretion of discounts on marketable securities
    		-459,000 -1,079,000 1,106,000 1,644,000                     
      changes in operating assets and liabilities:
    		                        
      accounts receivable
    		15,011,000 22,566,000 -69,732,000 41,705,000 9,917,000 -1,378,000 -60,118,000 22,023,000 -9,075,000 43,736,000 -78,422,000 13,859,000 -31,758,000 -35,560,000 -65,845,000 -1,938,000 3,170,000 -26,388,000 -43,520,000 -384,000 -14,552,000 -346,000 -20,054,000 -2,998,000 
      prepaid expenses and other current assets
    		-6,913,000 -5,563,000 -2,383,000 20,414,000 -3,675,000 -13,890,000 15,169,000 -20,407,000 6,666,000 -7,733,000 -1,456,000 -1,658,000 1,294,000 1,085,000 -664,000 261,000         
      accounts payable
    		-17,547,000 -4,411,000 49,618,000 -35,340,000 -21,324,000 21,606,000 4,790,000 -6,649,000 2,031,000 -15,592,000 36,445,000 4,982,000 11,632,000 7,904,000 23,171,000 6,166,000 583,000 -2,706,000 13,797,000 1,289,000 10,886,000 -7,526,000 20,359,000 -3,323,000 
      accrued expenses and other current liabilities
    		7,465,000 -11,657,000 17,509,000 -3,208,000 4,272,000 -4,135,000 12,995,000 -1,383,000 -2,085,000 2,078,000 11,751,000 -3,183,000 739,000 9,102,000 6,489,000 -10,905,000 3,552,000 124,000 9,413,000 2,381,000 6,549,000 5,214,000 3,256,000 266,000 
      other noncurrent assets and liabilities
    		1,194,000 -416,000 -738,000 421,000 -382,000 255,000 131,000 156,000 -89,000 360,000 221,000 130,000 158,000 6,000 -1,374,000 -2,288,000 -1,012,000 13,000 7,000 -72,000 350,000    
      net cash from operating activities
    		50,671,000 55,510,000 49,808,000 52,164,000 44,515,000 56,694,000 25,732,000 37,659,000 54,182,000 76,012,000 20,961,000 51,517,000 20,894,000 19,246,000 -11,262,000 8,815,000 24,163,000 -7,473,000 532,000 6,537,000 15,329,000 2,197,000 12,140,000 -5,489,000 
      capex
    		-4,684,000 -5,269,000 -2,843,000 -1,895,000 -1,794,000 -866,000 -850,000 -681,000 -953,000 -759,000 -1,251,000 -721,000 -1,240,000 -490,000 -790,000 -612,000 -718,000 -430,000 -369,000 -97,000 -149,000 -98,000 -693,000 -2,278,000 
      free cash flows
    		45,987,000 50,241,000 46,965,000 50,269,000 42,721,000 55,828,000 24,882,000 36,978,000 53,229,000 75,253,000 19,710,000 50,796,000 19,654,000 18,756,000 -12,052,000 8,203,000 23,445,000 -7,903,000 163,000 6,440,000 15,180,000 2,099,000 11,447,000 -7,767,000 
      investing activities
    		                        
      purchase of property and equipment
    		-4,684,000 -5,269,000 -2,843,000 -1,895,000 -1,794,000 -866,000 -850,000 -681,000 -953,000 -759,000 -1,251,000 -721,000 -1,240,000 -490,000 -790,000 -612,000 -718,000 -430,000 -369,000 -97,000 -149,000 -98,000 -693,000 -2,278,000 
      purchase of marketable securities
    		-111,425,000 -54,279,000 -145,809,000 0 -11,700,000 -47,833,000 -110,806,000 -166,733,000 -142,362,000 -97,164,000 -23,435,000 -38,178,000 -30,545,000 -34,744,000 -59,867,000 -20,996,000 -7,000,000 -21,335,000 -62,146,000 -38,986,000     
      sale of marketable securities
    		73,365,000 29,633,000 63,382,000 76,885,000 28,856,000 140,099,000 131,000,000 74,000,000 79,000,000 39,000,000 40,813,000 37,726,000 29,909,000 33,975,000 21,099,000 15,296,000 30,092,000 52,989,000 23,995,000 50,970,000     
      acquisition of business, net of cash acquired
    		0 0 -9,340,000 0 0                    
      net cash from investing activities
    		-42,744,000 -29,915,000 -94,610,000  15,362,000 86,096,000 19,344,000 -93,414,000 -64,315,000 -58,923,000 16,127,000 -1,173,000 -1,876,000 -1,259,000 -39,558,000 -6,312,000    11,887,000 -9,148,000 -42,077,000 -693,000 -2,278,000 
      financing activities
    		                        
      repurchase of common stock
    		   -55,102,000 -61,453,000 -159,959,000 -23,764,000                 -3,000 
      proceeds from exercise of stock options
    		5,000 -21,000 39,000 2,000 109,000 26,000 962,000 1,277,000 449,000 1,449,000 1,675,000 943,000 921,000 379,000 830,000 1,171,000 562,000 652,000 539,000 251,000 649,000    
      issuance costs on credit facility
    		                        
      payment of employee taxes related to equity awards
    		-2,625,000 -2,612,000 -3,583,000 -1,612,000 -2,217,000 -3,213,000 -4,959,000 -6,696,000 -3,078,000 -3,611,000 -3,815,000 -4,132,000 -2,322,000 -2,647,000 -2,988,000 -4,860,000 -3,815,000 -5,768,000 -3,523,000 -2,511,000 -2,323,000    
      proceeds from contributions to employee stock purchase plan
    		221,000 304,000 256,000 385,000 208,000 357,000 350,000 394,000 267,000 323,000 294,000 403,000 173,000 190,000 386,000 375,000 193,000 292,000 487,000 176,000 167,000    
      net cash from financing activities
    		-5,486,000 -2,329,000 -3,288,000 -56,327,000 -63,353,000 -162,789,000 -27,411,000 -5,025,000 -2,362,000 -1,839,000 -1,846,000 -2,786,000 -1,228,000 -2,078,000 -1,772,000     -2,084,000 -1,608,000 -2,363,000 -194,000 80,485,000 
      effect of exchange rate changes on cash, cash equivalents, and restricted cash
    		-3,000 37,000 15,000                      
      net decrease in cash, cash equivalents, and restricted cash
    		2,438,000                        
      cash, cash equivalents, and restricted cash, beginning of period
    		0 0 162,314,000                      
      cash, cash equivalents, and restricted cash, end of period
    		2,438,000 23,303,000 114,239,000                      
      cash and cash equivalents
    		1,476,000 23,267,000 109,239,000                      
      restricted cash included within noncurrent assets
    		962,000 36,000 5,000,000                      
      total cash, cash equivalents, and restricted cash
    		2,438,000 23,303,000 114,239,000                      
      supplemental disclosure of cash flow information
    		                        
      cash paid for income taxes, net of refunds received
    		15,556,000 23,942,000 400,000 5,577,000 17,555,000 17,679,000 -362,000 3,863,000 1,620,000 718,000 -20,000 -13,000 86,000 55,000 5,000          
      supplemental disclosure of non-cash investing and financing activities
    		                        
      additions of property and equipment, net included in accounts payable and accrued expenses
    		313,000 -778,000 1,246,000 105,000 -14,000 3,000 155,000 293,000 -310,000 237,000 201,000 560,000 -227,000 52,000 251,000 -58,000 164,000 78,000 20,000 -9,000     
      non-cash interest income
    		     113,000 -190,000 -92,000                 
      foreign currency exchange rate loss
    		      35,000 -20,000                 
      net increase in cash, cash equivalents, and restricted cash
    		  -48,075,000                      
      deferred tax (benefit) expense
    		               -15,447,000 -7,679,000        
      net cash provided (used in) by investing activities
    		                        
      effect of exchange rate changes on cash and cash equivalents
    		   7,000 -4,000 0 -2,000 1,000 0                
      net increase in cash and cash equivalents
    		   70,834,000 -3,480,000 -19,999,000 17,663,000 -60,779,000 -12,495,000 15,250,000 35,242,000 47,558,000    -811,000   -40,485,000 16,340,000 4,573,000 -42,242,000 11,252,000 72,718,000 
      cash and cash equivalents, beginning of year
    		                       0 
      cash and cash equivalents, end of year
    		                       72,718,000 
      cash and cash equivalents, beginning of period
    		    0 0 97,296,000  0 0 120,078,000  0 0 91,413,000  0 0 70,305,000  0 0 80,382,000  
      cash and cash equivalents, end of period
    		    -3,480,000 -19,999,000 114,959,000  -12,495,000 15,250,000 155,320,000  17,790,000 15,909,000 38,821,000  43,477,000 18,927,000 29,820,000  4,573,000 -42,242,000 91,634,000  
      realized gains on sale of marketable securities
    		     -3,592,000 -3,395,000    -502,000              
      foreign currency exchange rate gain
    		                        
      realized gain on sale of marketable securities
    		       -1,627,000 -1,377,000                
      deferred tax benefit
    		          -1,347,000 127,000 -1,672,000 85,000 -5,155,000          
      payment of initial public offering costs
    		                   0 -101,000 0 -791,000  
      net decrease in cash and cash equivalents
    		             15,909,000 -52,592,000          
      ​
    		                        
      change in fair value of warrant liabilities
    		                       5,757,000 
      net cash from continuing operations
    		                     2,197,000 12,140,000 -5,489,000 
      net cash from discontinued operations
    		                        
      proceeds from issuance of common stock upon initial public offering
    		                        
      proceeds from revolving line of credit
    		                       24,175,000 
      repayments made against revolving line of credit
    		                       -24,175,000 
      proceeds from exercise of stock warrants
    		                        
      cash paid for interest
    		                       0 
      deferred initial public offering costs in accounts payable and accrued expenses
    		                        
      non-cash preferred stock warrant conversion to common stock warrant upon ipo
    		                        
      net cash (used in) financing activities
    		                -3,060,000 -4,824,000 -2,497,000      
      prepaid expenses and current other assets
    		                 445,000 1,046,000 -3,945,000 1,949,000 1,109,000 561,000 -3,666,000 
      net cash (used in) investing activities
    		                 31,224,000 -38,520,000      
      net (decrease) in cash and cash equivalents
    		                        
      less: income from discontinued operations, net of income tax
    		                        
      loss on debt extinguishment
    		                        
      accretion of debt discount and debt issuance costs
    		                        
      net cash (used in) continuing operations
    		                   11,887,000 -9,148,000 -42,077,000 -693,000  
      repayment of term loan
    		                        
      repurchase of convertible preferred stock
    		                        
      exercise of stock warrants
    		                        
      non-cash settlement of liability
    		                        
      non-cash liability forgiveness related to divestiture
    		                        
      purchases of marketable securities
    		                        
      additions of property and equipment, net included in accrued expenses
    		                     21,000 68,000  
      non-cash deferred initial public offering costs in accounts payable and accrued liabilities
    		                       -1,402,000 
      exercise of stock options
    		                      597,000 1,529,000 
      supplemental disclosure of non-cash investing activities
    		                        
      other assets
    		                       287,000 
      proceeds from issuance of common stock upon initial public offering, net of issuance and offering costs
    		                        
      proceeds from issuance of convertible preferred stock and warrants
    		                        
      payment of deferred initial public offering costs
    		                        
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.